Adriamycin pfs and Maxalt drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Adriamycin pfs (doxorubicin hydrochloride) and Maxalt (rizatriptan benzoate). Common drug interactions include abdominal pain among females.
The phase IV clinical study analyzes what interactions people have when they take Adriamycin pfs and Maxalt. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.
What is Adriamycin pfs?
Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users. Check the latest studies of Adriamycin pfs.
What is Maxalt?
Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.
24 people who take Adriamycin pfs and Maxalt together, and have interactions are studied.
What are the common drug interactions of Adriamycin Pfs and Maxalt, by gender? *:
female:
- Abdominal pain
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Impaired healing
- Lung neoplasm malignant (cancer tumour of lung)
- Nausea (feeling of having an urge to vomit)
- Neoplasm (tumour)
- Oedema peripheral (superficial swelling)
- Ovarian cancer (cancer of ovary)
- Pain in jaw
- Platelet count decreased
male:
n/a
What are the common drug interactions of Adriamycin Pfs and Maxalt, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Abdominal pain
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Impaired healing
- Lung neoplasm malignant (cancer tumour of lung)
- Nausea (feeling of having an urge to vomit)
- Neoplasm (tumour)
- Oedema peripheral (superficial swelling)
- Ovarian cancer (cancer of ovary)
- Pain in jaw
- Platelet count decreased
60+:
n/a
What are the existing conditions these people have? *
- Ovarian Cancer (cancer of ovary): 24 people, 100.00%
- Neoplasm Malignant (cancer tumour): 24 people, 100.00%
- Hot Flush (sudden feelings of heat): 24 people, 100.00%
- Discomfort: 24 people, 100.00%
- Breast Cancer Metastatic: 24 people, 100.00%
- Breast Cancer: 24 people, 100.00%
- Granulocyte Count Decreased: 23 people, 95.83%
* Approximation only. Some reports may have incomplete information.
Do you take Adriamycin pfs and Maxalt?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Adriamycin pfs (6,495 reports)
- Maxalt (12,754 reports)
Browse all drug interactions of Adriamycin pfs and Maxalt:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Adriamycin pfs:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Maxalt:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Adriamycin pfs and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Maxalt and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on doxorubicin hydrochloride and rizatriptan benzoate (the active ingredients of Adriamycin pfs and Maxalt, respectively), and Adriamycin pfs and Maxalt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Ranitidine and Lorazepam - now
- Could Spiriva cause Lung Cancer Metastatic? - a second ago
- Could Clopidogrel Bisulfate cause Mental Status Changes? - 2 seconds ago
- Drug interactions of Adderall and Lacosamide - 3 seconds ago
- Could Megace cause Heart Rate Increased? - 9 seconds ago
- Could Modafinil cause Oral Herpes? - 13 seconds ago
- Could Ventolin cause Tic? - 25 seconds ago
- Drug interactions of Vitamin D and Westcort - 30 seconds ago
- Could Toradol cause Radicular Pain? - 32 seconds ago
- Pataday vs. Zantac 150, side effect and effectiveness comparison - 41 seconds ago